Explore migraine in men vs women differences including attack frequency, hormonal triggers, symptom profiles, and why sex and gender shape diagnosis and care.
Understanding migraine in men vs women differences is not just an academic exercise. It shapes how attacks are recognized, how quickly a diagnosis is reached, and how care is approached across a lifetime. Migraine affects roughly one billion people globally, but the experience is not uniform. Biological sex, hormonal status, and social factors all influence who gets migraine, how often, how severely, and how well it is managed.
Migraine is not simply a bad headache distributed randomly across the population. The condition has a strong sex-linked pattern. Before puberty, migraine rates are roughly similar in boys and girls, or slightly higher in boys. After puberty, that pattern reverses substantially. Women experience migraine at roughly two to three times the rate of men during the reproductive years. After menopause, the gap narrows again.
This shift tracks directly with hormonal changes. Estrogen, in particular, has a well-documented relationship with migraine susceptibility. Estrogen receptors are present throughout the brain and in the trigeminal pain pathway. When estrogen levels fluctuate, especially when they fall sharply, migraine risk increases. This is why the days just before menstruation, when estrogen drops, are a peak vulnerability window for many women.
Understanding what CGRP is and how it relates to migraine helps explain the underlying biology. CGRP (calcitonin gene-related peptide) is one of the key molecules in migraine pain signaling, and its release and regulation appear to be influenced by sex hormones, which may partly explain the differences in attack frequency and severity between sexes.
Women are more likely than men to experience frequent attacks, and they are also more likely to transition from episodic migraine to chronic migraine. Chronic migraine is defined as 15 or more headache days per month, with at least 8 meeting migraine criteria. The hormonal cycling that increases attack frequency in women also increases cumulative exposure to the sensitization processes that can drive chronification.
Men are more likely to remain in the episodic range, though episodic migraine in men can still carry significant disability. The episodic vs. chronic migraine distinction matters for care planning, and clinicians typically assess where a patient falls on that spectrum regardless of sex.
On average, migraine attacks in women last longer than those in men. Women's attacks more commonly extend into the 24 to 72 hour range, while men's attacks more often resolve within 24 hours. This is a statistical tendency rather than a rule, and individual attacks can vary widely.
Women more frequently report prominent nausea, vomiting, photophobia (light sensitivity), and phonophobia (sound sensitivity) during attacks. These associated symptoms contribute substantially to disability, because they often make it impossible to function even when head pain alone might be manageable.
Men more commonly report unilateral (one-sided) throbbing pain as the dominant feature. Nausea and sensory sensitivity occur in men too, but they tend to be reported as less overwhelming. Men also have a higher rate of cluster headache, a different but related primary headache disorder that can be confused with migraine, which may affect how their headache patterns are categorized.
Many triggers are shared across sexes: sleep disruption, skipped meals, dehydration, stress, and specific foods or drinks. But some triggers show sex-linked patterns.
In women, hormonal changes are the most distinctly sex-specific trigger category. Perimenstrual migraine, attacks that cluster in the two days before through the three days after the start of menstruation, are well recognized. Pregnancy and perimenopause also bring shifts in attack pattern, sometimes for better and sometimes for worse.
In men, alcohol (particularly red wine and beer) appears as a trigger somewhat more prominently in research, though the mechanism is not fully understood. Physical exertion as a trigger also appears relatively more in men, though exertional migraine affects people of all sexes.
Using a migraine trigger identifier can help anyone, regardless of sex, build a clear picture of which inputs reliably precede attacks.
One of the most clinically significant migraine differences between sexes is how often it goes undiagnosed or misdiagnosed in each direction.
Migraine carries a cultural perception of being predominantly a condition affecting women. This means that when men present with severe headaches, migraine may be lower on the list of considerations, both for the patient and sometimes for the clinician. Men are also less likely to seek medical care for recurrent headaches and less likely to describe associated symptoms in detail.
The result is that men with migraine often go years without an accurate diagnosis. They may be told their headaches are tension-type, sinus-related, or stress-related when migraine is the more accurate diagnosis. This delays access to appropriate care.
Women face a different problem: headaches in women are sometimes attributed to menstrual cycle effects in ways that can dismiss the seriousness of the condition or delay investigation of other factors. A woman whose migraine is written off as "hormonal headaches" may not receive a formal migraine diagnosis or appropriate preventive care.
Both of these patterns share a common solution: tracking symptoms in detail and bringing that record to a clinician. The MIDAS and HIT-6 questionnaires are standardized tools that quantify migraine's functional impact, and they apply equally regardless of sex. A disability score is a disability score. It moves the conversation from subjective description to documented impact.
Several hormonal transitions alter migraine patterns in women, and knowing what to expect helps in planning care.
Migraine often emerges or becomes more frequent at puberty. For girls who had occasional headaches in childhood, the onset of menstruation can mark a shift to a more established migraine pattern.
Migraine during pregnancy is variable. Some women see significant improvement, particularly in the second and third trimesters, as estrogen levels rise and stabilize. Others experience worsening, especially in the first trimester or in the postpartum period when estrogen drops sharply after delivery.
The perimenopausal transition, marked by erratic estrogen fluctuation, often worsens migraine frequency before the post-menopausal period, when many women see improvement. The years immediately before menopause can be among the most challenging for migraine management.
Hormonal therapies add another layer of complexity. Their effect on migraine varies substantially by individual and by formulation. A clinician is the right person to help weigh these factors, especially given that certain migraine types (migraine with aura) interact with some hormonal therapies in ways that require careful evaluation.
Despite the differences, the fundamentals of migraine as a neurological condition are the same across sexes. The trigeminal pain pathway is activated in the same way. CGRP is released during attacks in both sexes. The phases of prodrome, aura (in those who experience it), headache, and postdrome follow the same structure. Preventive and acute care approaches draw from the same categories of options for everyone.
The migraine symptom checker is a useful starting point for anyone trying to organize their symptom picture before a clinical appointment, regardless of sex.
Because sex-linked patterns in migraine are tendencies rather than predictable individual blueprints, the most useful thing any person with migraine can do is document what is actually happening in their own experience. Attack frequency, duration, symptom profile, triggers, and the relationship to hormonal events (for those for whom this is relevant) all add up to a clinical picture that no average or statistic can substitute for.
Consistent tracking over two to three months gives a clinician the data needed to see patterns, adjust care, and understand whether the condition is stable, improving, or progressing. Logging in detail, including symptom type, timing, and potential triggers, means your care team is working with your actual history rather than assumptions based on population averages. That distinction matters, and it starts with the record you keep.
Educational, not medical advice. Migraine Tracker: CGRP Log is a personal tracking tool, not a medical device. It does not diagnose, treat, or provide medical advice. Always talk to your clinician.
Estrogen plays a significant role. Fluctuating estrogen levels, particularly the drop before menstruation, are a well-established migraine trigger. Because women experience these hormonal shifts cyclically, their overall migraine frequency tends to be higher. That said, migraine affects people of all sexes, and men often go underdiagnosed because the condition is less expected in them.
Learn how menopause and migraine hormones perimenopause are connected, what to expect as estrogen fluctuates, and how tracking helps your care team.
Learn what migraine during pregnancy looks like across each trimester, why patterns shift, and how to work with your care team to manage symptoms safely.
How migraine and sleep disorders comorbidity works, why insomnia and sleep apnea worsen attack frequency, and what to log for your clinician.
